Pfizer CEO says fourth COVID-19 shot ‘necessary’ due to waning immunity
- Thread starter AndrewX
- Start date
Well have fun in the intervention group then. I'll stay in the control thank you.
And we will see how this experiment of a mRNA vaccine ( gene therapy) works out.......
Never going to happen.
Herd immunity is impossible with this virus.
Just ask the good citizens of Gibraltar. Gibraltar who 100% vaccinated and still had to be locked down because of the rising spread.
Now your dissing a Paleo diet?.......LOL.....How's your impossible burger taste?
I know for a fack the vaccine protected millions from getting seriously sick or dying. So yeah I will continue to trust science to protect myself.
mRNA is not gene therapy
Crazy to think some still believe that. By the way mRNA is a few years away to a vaccine against oncology based cancer. This is huge. No chemo! Affected by cancer there will be no more anti-vax believe me.
mRNA is not gene therapy
mRNA therapy: A new form of gene medicine
It has been several weeks since I came back from Berlin. I was visiting the international mRNA health conference, where I presented our…
Hmmm........
1)Based on your expertise/ advanced knowledge regarding viruses and epidemiology in general including herd immunity? (Please provide your educational qualifications)
2)Based on your studies of covid in particular? (qualifications)
3)Based on your gut feelings/a hunch?
4)Based on your political leanings? (we already know those)
Please tell us how you absolutely know that it will not and cannot ever happen with this virus. It is impossible.
Following up, here's a study that says the fourth vaccine doesn't do much. The Pfizer boss can't be happy with this study.
Fourth vaccine offers little protection against COVID-19 - study
Interim results released show that the vaccine offers little to no protection against the virus when compared to three doses.
The fourth coronavirus vaccine has shown to offer little protection against the coronavirus, a new study released by Sheba Medical Center has shown.
The study, published by The New England Journal of Medicine, examines the efficacy of the fourth coronavirus vaccine from Pfizer and Moderna. The interim results released show that the vaccine offers little to no protection against contracting the virus when compared to young and healthy individuals vaccinated with three doses.
However, the vaccine did prove to provide moderate protection against symptomatic infection among young and healthy individuals in comparison to those inoculated three times.
“Among the approximate 600 participants, 270 of whom received either a fourth dose of the Pfizer vaccine or Moderna vaccine, we found no differences, both in terms of IgG antibody levels and in terms of neutralizing antibody levels, which reached a level similar to that measured a month after the third dose was administered,” said Prof. Gili Regev-Yochay, director of the Infection Prevention and Control Unit at Sheba Medical Center and head researcher of the study.
She also noted that in terms of the effectiveness of the fourth vaccine against infection – both of Pfizer and Moderna – they found that the infection rates among vaccinated individuals were only slightly lower than those in the control group.
“However, it should be emphasized that the third dose is extremely important for anyone who has not yet contracted COVID-19, and the fourth dose is most likely important for populations with risk factors for which a fourth vaccine would protect from serious illness.
“This study is added to a series of studies led by Sheba with the aim of providing a scientific basis for managing a pandemic that has wreaked havoc around the globe,” concluded Regev-Yochay.
“Thanks to the cohort at Sheba and the plethora of data we have accumulated since the beginning of the pandemic, we continue to lead international studies which shed light on the behavior of the virus and the effectiveness of vaccines and serve decision makers in determining health policy in Israel and around the world.”
www.jpost.com
Fourth vaccine offers little protection against COVID-19 - study
Interim results released show that the vaccine offers little to no protection against the virus when compared to three doses.
The fourth coronavirus vaccine has shown to offer little protection against the coronavirus, a new study released by Sheba Medical Center has shown.
The study, published by The New England Journal of Medicine, examines the efficacy of the fourth coronavirus vaccine from Pfizer and Moderna. The interim results released show that the vaccine offers little to no protection against contracting the virus when compared to young and healthy individuals vaccinated with three doses.
However, the vaccine did prove to provide moderate protection against symptomatic infection among young and healthy individuals in comparison to those inoculated three times.
“Among the approximate 600 participants, 270 of whom received either a fourth dose of the Pfizer vaccine or Moderna vaccine, we found no differences, both in terms of IgG antibody levels and in terms of neutralizing antibody levels, which reached a level similar to that measured a month after the third dose was administered,” said Prof. Gili Regev-Yochay, director of the Infection Prevention and Control Unit at Sheba Medical Center and head researcher of the study.
She also noted that in terms of the effectiveness of the fourth vaccine against infection – both of Pfizer and Moderna – they found that the infection rates among vaccinated individuals were only slightly lower than those in the control group.
“However, it should be emphasized that the third dose is extremely important for anyone who has not yet contracted COVID-19, and the fourth dose is most likely important for populations with risk factors for which a fourth vaccine would protect from serious illness.
“This study is added to a series of studies led by Sheba with the aim of providing a scientific basis for managing a pandemic that has wreaked havoc around the globe,” concluded Regev-Yochay.
“Thanks to the cohort at Sheba and the plethora of data we have accumulated since the beginning of the pandemic, we continue to lead international studies which shed light on the behavior of the virus and the effectiveness of vaccines and serve decision makers in determining health policy in Israel and around the world.”
Fourth vaccine offers little protection against COVID-19 - study
Interim results released show that the vaccine offers little to no protection against the virus when compared to three doses.
www.jpost.com
Doubt it will ever happen for Covid, it keeps changing it's colour
The percentage of people who need to be immune in order to achieve herd immunity varies with each disease. For example, herd immunity against measles requires about 95% of a population to be vaccinated. The remaining 5% will be protected by the fact that measles will not spread among those who are vaccinated.
For polio, the threshold is about 80%. The proportion of the population that must be vaccinated against COVID-19 to begin inducing herd immunity is not known.
Not designed to alter your genes... https://www.reuters.com/article/factcheck-covid-mrna-gene-idUSL1N2PH16NmRNA therapy: A new form of gene medicine
It has been several weeks since I came back from Berlin. I was visiting the international mRNA health conference, where I presented our…medium.com
Hmmm........
Yup, 1-1/R nought is the "rule of thumb" level of non-susceptible people.
Given the various variants seem to have different R-nought, that's been hard to manage or anticipate. (Let alone vaccine escape.)
In the end, it is all just about getting effective R down below 1 - especially when there is a spike.
So the third dose is pretty good except some populations might need the forth which would not be picked up in studies of general populations.
Good to know.
The charade is over.Following up, here's a study that says the fourth vaccine doesn't do much. The Pfizer boss can't be happy with this study.
Fourth vaccine offers little protection against COVID-19 - study
Interim results released show that the vaccine offers little to no protection against the virus when compared to three doses.
The fourth coronavirus vaccine has shown to offer little protection against the coronavirus, a new study released by Sheba Medical Center has shown.
The study, published by The New England Journal of Medicine, examines the efficacy of the fourth coronavirus vaccine from Pfizer and Moderna. The interim results released show that the vaccine offers little to no protection against contracting the virus when compared to young and healthy individuals vaccinated with three doses.
However, the vaccine did prove to provide moderate protection against symptomatic infection among young and healthy individuals in comparison to those inoculated three times.
“Among the approximate 600 participants, 270 of whom received either a fourth dose of the Pfizer vaccine or Moderna vaccine, we found no differences, both in terms of IgG antibody levels and in terms of neutralizing antibody levels, which reached a level similar to that measured a month after the third dose was administered,” said Prof. Gili Regev-Yochay, director of the Infection Prevention and Control Unit at Sheba Medical Center and head researcher of the study.
She also noted that in terms of the effectiveness of the fourth vaccine against infection – both of Pfizer and Moderna – they found that the infection rates among vaccinated individuals were only slightly lower than those in the control group.
“However, it should be emphasized that the third dose is extremely important for anyone who has not yet contracted COVID-19, and the fourth dose is most likely important for populations with risk factors for which a fourth vaccine would protect from serious illness.
“This study is added to a series of studies led by Sheba with the aim of providing a scientific basis for managing a pandemic that has wreaked havoc around the globe,” concluded Regev-Yochay.
“Thanks to the cohort at Sheba and the plethora of data we have accumulated since the beginning of the pandemic, we continue to lead international studies which shed light on the behavior of the virus and the effectiveness of vaccines and serve decision makers in determining health policy in Israel and around the world.”
Fourth vaccine offers little protection against COVID-19 - study
Interim results released show that the vaccine offers little to no protection against the virus when compared to three doses.
‘We probably would have had a 95% refusal rate’ for these shots two years ago, but the pandemic and marketing of the injections as ‘vaccines’ has made them popular with the public, said Stefan Oelrich.
Without help from the global pandemic people may never have been convinced to inject themselves with an experimental mRNA gene therapy, a scientist bragged during a world health conference.
Speaking at the opening of the World Health Summit 2021 last November, Bayer Pharmaceuticals Division President Stefan Oelrich admitted were it not for the pandemic, the experimental injection may have seen an extremely high rejection rate.
The smart people buy shares in profitable companies. I guess that that doesn't include you...
So we need a booster once a year. Combo shots have been around for many years. MMR and Tdap immediately come to mind.
It will be interesting to see, but I believe that faced with cancer, the anti-mRNA crowd will gladly seek the treatment if it's effective. Or will they refuse it? Telling the doctor it's gene therapy and they have numerous Facebook and YouTube videos to prove it!I know for a fact the vaccine protected millions from getting seriously sick or dying. So yeah I will continue to trust science to protect myself.
mRNA is not gene therapy
Last edited:
2 vaccines are currently being research of upmost importance.The smart people buy shares in profitable companies. I guess that that doesn't include you...
So we need a booster once a year. Combo shots have been around for many years. MMR and Tdap immediately come to mind.
- mRNA cancer vaccine
If they succeed it will change cancer treatment for many type of cancer. Big breakthrough. Imagine beating cancer without chemo!
- Coronavirus vaccine
Many teams of researcher are working on vaccine that would work for all type of corona based virus.
Some have said if asked if they would take a cancer vaccine would say no.
Keep in mind, such a vaccine doesn't exist, there is no data on it what so ever. Flat out no.
At least cancer isn't contagious. Pity that those ignorent fucks would still insist that the government pay for their chemo. Just because out of ignorance they wouldn't take a shot that has been tested and approved for use. Keep in mind we are not talking about people who have been unable to overcome a food or tobacco addiction, just a simple fucking shot.
